Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2

M McLaughlin1, S A Karim, P Montague

  • 1Applied Neurobiology Group, Division of Cell Sciences, Institute of Comparative Medicine, University of Glasgow, Bearsden, Glasgow, G61 1QH, Scotland.

Neurochemical Research
|September 1, 2006
PubMed

Insights

Genetic background significantly impacts the severity of Pelizaeus-Merzbacher disease (PMD) in mice with the rumpshaker mutation. Protein processing differences do not explain this phenotypic variation, suggesting other factors influence disease progression.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Mutations in the proteolipid protein gene (PLP1) are linked to Pelizaeus-Merzbacher disease (PMD) and Spastic paraplegia type 2 (SPG2).
  • The rumpshaker mutation in PLP1 causes milder forms of these neurological disorders in humans and mice.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the variable phenotypic severity of the rumpshaker mutation in different mouse genetic backgrounds.
  • To determine if differences in proteolipid protein (PLP) processing or unfolded protein response (UPR) pathways contribute to the observed phenotypic variation.

Main Methods:

  • Comparative analysis of PLP/DM20 synthesis, degradation, and myelin incorporation rates in C3H and C57BL/6 mice carrying the rumpshaker mutation.
  • Assessment of unfolded protein response (UPR) activation, including the expression of CHOP, BiP, and Xbp1, in relation to phenotypic severity.

Main Results:

  • The rumpshaker mutation leads to a lethal phenotype in C57BL/6 mice, contrasting with a milder form in C3H mice, despite similar PLP/DM20 synthesis, degradation, and myelin incorporation rates across both backgrounds.
  • An unfolded protein response (UPR) is activated in rumpshaker mutants, with CHOP activation correlating with disease severity.
  • No significant differences were observed in the activation of BiP and X-box protein1 (Xbp1) between the two mouse strains, suggesting these specific UPR components are not primary drivers of the phenotypic variation.

Conclusions:

  • Phenotypic variation in rumpshaker-associated neurological disorders is not solely due to differences in PLP/DM20 protein processing.
  • The severity of the disease phenotype is linked to the activation of specific components of the unfolded protein response (UPR), such as CHOP.
  • The genetic background plays a critical role in modulating the impact of PLP1 mutations on disease outcome.

Related Concept Videos

Position-effect Variegation02:32

Position-effect Variegation

In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...